A review on liposome as a drug delivery system for antibiotics
Department of Pharmaceutics, Shri Swami Samarth Institute of Pharmacy, At Parsodi, Dhamangoan Rly, Dist -Amravati (444709) Maharashtra, India.
Review Article
GSC Biological and Pharmaceutical Sciences, 2024, 28(01), 017–029.
Article DOI: 10.30574/gscbps.2024.28.1.0248
Publication history:
Received on 14 May 2024; revised on 26 June 2024; accepted on 29 June 2024
Abstract:
Antimicrobial medications are essential for both treating and preventing bacterial infections. The growth and spread of resistant bacteria pose significant obstacles to the current management of bacterial diseases, notwithstanding the early effectiveness of antibiotics. It is imperative to take action to prevent and manage antibiotic resistance in order to prevent a potentially catastrophic clinical collapse. World Health Organisation (WHO) and national health authorities have mostly recommended action plans to limit the use of antibiotics while enhancing hygiene and drug disposal practices. Our goal in writing this review is to discuss how well antibiotic-encapsulated liposomes work as a treatment for bacterial illnesses.
Keywords:
Liposome; Antibiotics; Bilayer Vesicles; Antimicrobs; Phospholipid Bilayer
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
